Imago BioSciences, Inc.
IMGODelisted Jan 11, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001623715
Imago BioSciences, Inc. was delisted on Jan 11, 2023; its insiders filed their last Form 4 on Jan 11, 2023; 106 institutions reported holding it in 13F filings for Q4 2022, worth $1.05B in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Imago BioSciences, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 62 | 65 | +3 |
| Shares | 31.1M | 31.8M | +631.9K (+2.0%) |
| Value | $416.8M | $478.1M | +$61.2M (+14.7%) |
New holders (7)
Institutions that held Imago BioSciences, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Soleus Capital Management, L.P. | 213,000 | $3.21M | 0.44% |
| Monarch Partners Asset Management LLC | 148,915 | $2.24M | 0.67% |
| Mirae Asset Global Investments Co., Ltd. | 11,933 | $180.0K | 0.00% |
| Voya Investment Management LLC | 10,617 | $159.8K | 0.00% |
| UBS Group AG | 1,481 | $22.0K | 0.00% |
| Quantbot Technologies LP | 700 | $10.0K | 0.00% |
| China Universal Asset Management Co., Ltd. | 316 | $5.00K | 0.00% |
Sold out (4)
Institutions that held Imago BioSciences, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Trexquant Investment LP | 32,045 | $429.0K |
| AlpInvest Partners B.V. | 30,156 | $404.0K |
| Gsa Capital Partners LLP | 23,835 | $319.0K |
| Susquehanna International Group, LLP | 12,473 | $167.0K |